STAT3 and B-cell chronic lymphocytic leukemia: Cells from seven CLL patients (described in Table 1) were treated with 40 μM CNL or ghost nanoliposomes (no C6-ceramide) for 24 h and STAT3 phosphorylation was evaluated.